CAS 1698024-73-5

Formule : C21H17ClF2N4O2

InChI : InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2

Code InChI : ZRPZPNYZFSJUPA-UHFFFAOYSA-N

SMILES : C=CC(=O)N1CCN(CC1)C2=NC=NC3=C(C(=C(C=C32)Cl)C4=C(C=CC=C4F)O)F

ARS-1323

CAS : 1698024-73-5

ARS-1323

Formule : C₂₁H₁₇ClF₂N₄O₂

Degré de pureté : ≥98%

Masse moléculaire : 430.84

Ref: 54-BUP07005

ARS-1323

CAS : 1698024-73-5

Formule : C₂₁H₁₇ClF₂N₄O₂

Masse moléculaire : 430.8351

Ref: IN-DA01EOLG

ARS-1620

CAS : 1698024-73-5

ARS-1620 is a small-molecule inhibitor, which is derived from advanced medicinal chemistry efforts focused on targeting specific oncogenic mutations. This compound is synthesized with the precise intent to address challenges posed by mutant KRAS G12C, a particularly intractable target given its prevalence in various cancers such as lung and colorectal cancers.

Formule : C₂₁H₁₇ClF₂N₄O₂

Degré de pureté : Min. 95%

Masse moléculaire : 430.84 g/mol

Ref: 3D-YSC02473

ARS-1323

CAS : 1698024-73-5

ARS-1323 is the racemate of ARS-1620 and a mutant K-ras G12C inhibitor.

Formule : C₂₁H₁₇ClF₂N₄O₂

Degré de pureté : 99.53%

Couleur et forme : Solid

Masse moléculaire : 430.84

Ref: TM-T10375